Overview
EncrypGen is a company identified as part of the New York City AI scene[1]. The company develops software for safely storing and sharing genomic data for research and science, and enables users to manage their own data and sell it to researchers[2]. Founded in 2016, EncrypGen was acquired by IndyGeneUS in 2022[2]. At the time of its acquisition, the company had 21 employees[3] and operated in the biotechnology research industry[3].
Growth & traction
Something wrong or missing? Send an update. Fixed within 24 hours.